Tumor Specific VEGF-A and VEGFR2/KDR Protein are Co-expressed in Breast Cancer Lisa RydénBarbro LinderholmGöran Landberg OriginalPaper Pages: 147 - 154
Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2 Marc AzemarSirus DjahansouziWinfried S. Wels OriginalPaper Pages: 155 - 164
The 870G>A Polymorphism of the Cyclin D1 Gene is not Associated with Breast Cancer Peter KripplUwe LangsenlehnerHellmut Samonigg OriginalPaper Pages: 165 - 168
Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model Edward L. NelsonDarue PrietoJonathan F. Smith OriginalPaper Pages: 169 - 183
Dose-dense Vinorelbine and Paclitaxel with Granulocyte Colony-stimulating Factor in Metastatic Breast Cancer Patients: Anti-tumor Activity and Peripheral Blood Progenitor Cell Mobilization Capability Alberto BallestreroFilippo MontemurroFranco Patrone OriginalPaper Pages: 185 - 190
A Potential Role for the Estrogen-metabolizing Cytochrome P450 Enzymes in Human Breast Carcinogenesis Francesmary ModugnoCarmela KnollMarjorie Romkes OriginalPaper Pages: 191 - 197
Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases George N. NaumovJason L. TownsonAnn F. Chambers OriginalPaper Pages: 199 - 206
Influence of Neoadjuvant Therapy with Epirubicin and Docetaxel on the Expression of HER2/neu in Patients with Breast Cancer Susanne TaucherMargaretha RudasRaimund Jakesz OriginalPaper Pages: 207 - 213
A Review of the Efficacy of Anastrozole in Postmenopausal Women with Advanced Breast Cancer with Visceral Metastases A. HowellJ.F.R. RobertsonI. Vergote OriginalPaper Pages: 215 - 222